108 related articles for article (PubMed ID: 20876772)
21. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
Erbel C; Chen L; Bea F; Wangler S; Celik S; Lasitschka F; Wang Y; Böckler D; Katus HA; Dengler TJ
J Immunol; 2009 Dec; 183(12):8167-75. PubMed ID: 20007582
[TBL] [Abstract][Full Text] [Related]
22. A functional role for inducible costimulator (ICOS) in atherosclerosis.
Afek A; Harats D; Roth A; Keren G; George J
Atherosclerosis; 2005 Nov; 183(1):57-63. PubMed ID: 15941568
[TBL] [Abstract][Full Text] [Related]
23. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
Stoll G; Bendszus M
Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
[TBL] [Abstract][Full Text] [Related]
24. Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis.
Mohanta SK; Yin C; Peng L; Srikakulapu P; Bontha V; Hu D; Weih F; Weber C; Gerdes N; Habenicht AJ
Circ Res; 2014 May; 114(11):1772-87. PubMed ID: 24855201
[TBL] [Abstract][Full Text] [Related]
25. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients.
Cross AH; Stark JL; Lauber J; Ramsbottom MJ; Lyons JA
J Neuroimmunol; 2006 Nov; 180(1-2):63-70. PubMed ID: 16904756
[TBL] [Abstract][Full Text] [Related]
26. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
[TBL] [Abstract][Full Text] [Related]
27. Deficiency of programmed cell death 4 results in increased IL-10 expression by macrophages and thereby attenuates atherosclerosis in hyperlipidemic mice.
Jiang Y; Gao Q; Wang L; Guo C; Zhu F; Wang B; Wang Q; Gao F; Chen Y; Zhang L
Cell Mol Immunol; 2016 Jul; 13(4):524-34. PubMed ID: 26166769
[TBL] [Abstract][Full Text] [Related]
28. Characterization of BIS20x3, a bi-specific antibody activating and retargeting T-cells to CD20-positive B-cells.
Withoff S; Bijman MN; Stel AJ; Delahaye L; Calogero A; Jonge MW; Kroesen BJ; Leij L
Br J Cancer; 2001 Apr; 84(8):1115-21. PubMed ID: 11308263
[TBL] [Abstract][Full Text] [Related]
29. [CD20 antibody for treatment of rheumatoid arthritis].
Tanaka Y
Nihon Rinsho; 2005 Jan; 63 Suppl 1():544-8. PubMed ID: 15799415
[No Abstract] [Full Text] [Related]
30. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
[TBL] [Abstract][Full Text] [Related]
31. Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.
Rao LN; Ponnusamy T; Philip S; Mukhopadhyay R; Kakkar VV; Mundkur L
Lipids; 2015 Aug; 50(8):785-97. PubMed ID: 26178198
[TBL] [Abstract][Full Text] [Related]
32. The role of B cell-mediated T cell costimulation in the efficacy of the T cell retargeting bispecific antibody BIS20x3.
Stel AJ; Kroesen BJ; Jacobs S; Groen H; de Leij LF; Kluin-Nelemans HC; Withoff S
J Immunol; 2004 Nov; 173(10):6009-16. PubMed ID: 15528335
[TBL] [Abstract][Full Text] [Related]
33. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.
Hasegawa M; Hamaguchi Y; Yanaba K; Bouaziz JD; Uchida J; Fujimoto M; Matsushita T; Matsushita Y; Horikawa M; Komura K; Takehara K; Sato S; Tedder TF
Am J Pathol; 2006 Sep; 169(3):954-66. PubMed ID: 16936269
[TBL] [Abstract][Full Text] [Related]
34. Lymphocytes in atherosclerosis.
Wigren M; Nilsson J; Kolbus D
Clin Chim Acta; 2012 Oct; 413(19-20):1562-8. PubMed ID: 22565046
[TBL] [Abstract][Full Text] [Related]
35. Comment on "Reduced T-dependent humoral immunity in CD20-deficient mice".
Golay J
J Immunol; 2013 Dec; 191(12):5783. PubMed ID: 24319281
[No Abstract] [Full Text] [Related]
36. CD20+ B cell depletion alters T cell homing.
Kap YS; van Driel N; Laman JD; Tak PP; 't Hart BA
J Immunol; 2014 May; 192(9):4242-53. PubMed ID: 24696233
[TBL] [Abstract][Full Text] [Related]
37. FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Zhao M; Wigren M; Dunér P; Kolbus D; Olofsson KE; Björkbacka H; Nilsson J; Fredrikson GN
J Immunol; 2010 Mar; 184(5):2253-60. PubMed ID: 20097865
[TBL] [Abstract][Full Text] [Related]
38. B cell depletion increases sphingosine-1-phosphate-dependent airway inflammation in mice.
Sorrentino R; Bertolino A; Terlizzi M; Iacono VM; Maiolino P; Cirino G; Roviezzo F; Pinto A
Am J Respir Cell Mol Biol; 2015 May; 52(5):571-83. PubMed ID: 25250941
[TBL] [Abstract][Full Text] [Related]
39. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence.
Björkbacka H; Fredrikson GN; Nilsson J
Atherosclerosis; 2013 Mar; 227(1):9-17. PubMed ID: 23177975
[TBL] [Abstract][Full Text] [Related]
40. B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD.H-2h4 mice.
Yu S; Dunn R; Kehry MR; Braley-Mullen H
J Immunol; 2008 Jun; 180(11):7706-13. PubMed ID: 18490774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
